AG真人官方

The Vanguard Group filed Amendment No. 3 to Schedule 13G disclosing a 9.35 % beneficial stake in Embecta Corp (CUSIP 29082K105) as of 06/30/2025. Vanguard reports ownership of 5,466,604 common shares.

Voting authority is limited: 0 shares with sole voting power and 90,901 shares with shared voting power. Dispositive authority is broader, covering 5,317,080 shares solely and 149,524 shares shared. The filing is made under Rule 13d-1(b) with Vanguard classified as an investment adviser (Type IA), indicating a passive investment purpose. Vanguard certifies the shares were acquired in the ordinary course of business and not to influence control of Embecta.

The document is signed by Ashley Grim, Head of Global Fund Administration, on 07/29/2025.

Toronto-Dominion Bank (TD) is offering US$1.263 million of Senior Debt Securities, Series H 鈥� Capped Notes linked to the S&P 500庐 Index, maturing 7 July 2028. The notes give investors unleveraged exposure to any positive performance of the index, capped at a Maximum Redemption Amount of US$1,240 per US$1,000 principal (24% total / c. 8% CAGR). If the Final Level of the index is equal to or below the Initial Level of 6,279.35, holders receive only their principal, resulting in full principal protection provided TD remains solvent. No periodic coupons are paid.

Key commercial terms

• Issue price: US$1,000 per note; minimum investment US$1,000.
• Term: ~3 years (Pricing Date 3 Jul 2025; Maturity 7 Jul 2028).
• Participation: 100% of positive index move, subject to the US$1,240 cap.
• Credit: senior unsecured obligations of TD; not CDIC/FDIC insured.
• Estimated value: US$986 鈥� 1.4% below issue price, reflecting structuring & hedging costs.
• Fees: up to 0.95% selling concession plus US$7 marketing fee; total underwriting discount c. 0.26% of notional shown (variable).
• Liquidity: no exchange listing; any secondary market making is discretionary and may be at significant discount.

Risk highlights

• Upside is capped; investors forego any index gain above 24%.
• No dividend participation 鈥� index tracked on a price-return basis.
• Return may underperform a conventional fixed-rate bond of similar maturity because the notes pay no coupons.
• Market value likely to fall below issue price after settlement due to bid/ask spreads, embedded fees and TD鈥檚 funding curve.
• Subject to TD credit risk; deterioration in TD credit spreads will pressure secondary pricing.
• Taxed as Contingent Payment Debt Instruments (CPDI); holders accrue taxable OID income annually despite no cash flows before maturity.

The instrument targets investors seeking principal protection with limited equity upside over a three-year horizon and who are comfortable with TD credit exposure and illiquidity. It is not appropriate for investors requiring current income, uncapped equity participation or near-term liquidity.

BioCardia, Inc. (Nasdaq: BCDA) filed a Rule 424(b)(5) prospectus supplement on July 8, 2025 to enlarge its ongoing at-the-market (ATM) equity program with H.C. Wainwright & Co. The supplement authorizes the sale of up to $3.63 million in additional common shares, over and above the roughly $3.1 million already issued under the existing Sales Agreement.

The company鈥檚 non-affiliate float is valued at approximately $12.8 million (4,487,631 shares at $2.85 per share as of May 9, 2025). Pursuant to Form S-3 General Instruction I.B.6, BioCardia may not sell more than one-third of this float within any 12-month period while its market value remains below $75 million; the new limit therefore aligns with the regulatory cap. To date, ATM sales during the current 12-month window total about $0.6 million, leaving the full $3.63 million capacity available.

The offering will be made 鈥渁t the market,鈥� meaning shares may be issued intermittently at prevailing prices, last reported at $2.10 per share on July 7, 2025. Proceeds are expected to support general corporate purposes. Investors should consider dilution risk and the previously disclosed risk factors incorporated from earlier prospectus filings.

GCL Global Holdings Ltd ("GCL") has filed Prospectus Supplement No. 8 and a Form 6-K to disclose a new warrant issuance linked to an existing SG$5 million credit facility extended to its wholly-owned subsidiary, Epicsoft Asia Pte. Ltd.

• Financing context: The facility, arranged with Oversea-Chinese Banking Corporation (OCBC) on 1 Oct 2024 and amended 12 Mar 2025, provides up to SG$5 million (鈮� US$3.75 million). One condition precedent for draw-down is issuance of a warrant to OCBC.
• Warrant terms: 鈥� Shares underlying warrant: 899,281 ordinary shares 鈥� Exercise price: US$4.17 per share 鈥� Aggregate exercise proceeds: US$3.75 million 鈥� Term: 5 years from 7 Jul 2025 鈥� Automatic exercise triggers if (i) VWAP > US$12 for 20 consecutive trading days, (ii) 鈮� 1 million average daily volume, (iii) market cap 鈮� US$1 billion, and (iv) an effective resale registration statement is available.
• Use of proceeds: All exercise proceeds will first repay outstanding amounts under the OCBC facility; any excess is earmarked for the subsidiary鈥檚 working capital.
• Dilution & registration: The warrant represents potential dilution of ~899k shares (鈮� 1.1% of the 83.5 million shares covered by the broader resale prospectus). GCL must file a resale registration statement for these warrant shares within six months (by 7 Jan 2026).
• Listing & compliance: Shares are listed on Nasdaq Global Select Market; GCL commits to maintain listing, register shares, and provide customary registration rights, indemnities and adjustment mechanisms.

The filing primarily informs investors of incremental potential dilution, outlines the company鈥檚 obligations to register the warrant shares, and clarifies that any cash from warrant exercise will reduce debt associated with the SG$5 million facility. No new earnings or operational metrics are provided.

Eos Energy Enterprises, Inc. (EOSE) 鈥� Form 144 filing discloses a proposed insider sale of common stock.

• Seller & broker: 47,254 common shares are to be sold for the account of Nathan Kroeker through UBS Financial Services Inc., Eleven Madison Ave., New York.
• Transaction size: Aggregate market value is $243,358.10, representing roughly 0.02 % of the 227,589,833 shares outstanding.
• Planned timing & venue: Sale is targeted for 07 / 08 / 2025 on the Nasdaq.
• Source of shares: Shares derive from RSU vesting on 07 / 05 / 2025; 47,254 units vested on that date.
• Recent selling activity: Over the last three months Kroeker sold 152,856 shares on 05 / 16 / 2025 for $1,048,853 and 24,124 shares on 07 / 07 / 2025 for $125,801.84.

The filing is a notice only; execution depends on market conditions, and Rule 144 limits apply. The volume is immaterial versus total shares, but the continued disposition may be monitored by investors assessing insider sentiment.

Legal & General Group Plc and affiliated investment entities filed Amendment No. 2 to Schedule 13G covering Eos Energy Enterprises, Inc. (EOSE) common stock as of 31 Dec 2022.

The group now reports 0 shares owned, representing 0.0 % of the outstanding class. Accordingly, it holds no sole or shared voting or dispositive power. Each subsidiary鈥攊ncluding Legal & General Investment Management Ltd, LGIM Managers (Europe) Ltd, Legal & General UCITS ETF Plc and Legal & General Investment Management America Inc鈥攁lso discloses zero ownership.

The filing indicates Legal & General has fully exited its prior position, reducing its stake below the 5 % reporting threshold. The document is signed by Mary Ann Colledge (Head of Conduct Advisory) on 07 Feb 2025.

Legal & General Group Plc and four affiliated investment entities have filed Amendment No. 1 to Schedule 13G for Eos Energy Enterprises, Inc. (EOSE). The group reports beneficial ownership of 2,899,961 common shares, representing 5.4 % of the outstanding class, with an event date of 12 / 31 / 2021 and signatures dated 07 / 02 / 2025.

All voting and dispositive authority is shared; none of the filers has sole power to vote or dispose of the shares. Reporting persons include Legal & General Investment Management Ltd, LGIM Managers (Europe) Ltd, Legal & General UCITS ETF Plc, and Legal & General Investment Management America Inc. Each filer is classified as a financial institution (FI) or investment adviser (IA). The disclosure signals continued passive institutional ownership above the 5 % threshold that triggers a Schedule 13G filing.

Eos Energy Enterprises, Inc. (EOSE) has filed a Form 144, indicating the intent of an insider to sell restricted shares under Rule 144.

• Shares to be sold: 24,124 common shares
• Estimated market value: US $125,565.42
• Broker: UBS Financial Services Inc., New York
• Planned sale date: 07 July 2025
• Total shares outstanding: 227,589,833
• Source of shares: RSU vesting on 03 July 2025
• Prior insider activity: The same account holder sold 152,856 shares on 16 May 2025 for US $1,048,853

The proposed sale represents roughly 0.01 % of EOSE鈥檚 outstanding shares. Rule 144 filings are routine for executives monetising equity compensation and do not, by themselves, signal a change in company fundamentals. However, the filing does extend a recent pattern of insider sales that investors may wish to monitor.

Wayfair Inc. (symbol W) has filed a Form 144 indicating the intention to sell 180,943 Class A shares through Fidelity Brokerage Services on or about 01 July 2025. The shares carry an aggregate market value of $9.51 million and represent roughly 0.17 % of the company鈥檚 103.66 million shares outstanding.

The shares were originally acquired on 01 January 2002 as 鈥淔ounder Shares鈥� received as compensation. Within the past three months, related parties named in the filing鈥擲teven K. Conine and the Conine Family Foundation鈥攈ave already sold 153,963 shares for total gross proceeds of approximately $6.71 million.

• Proposed sale class: Class A
• Broker: Fidelity Brokerage Services LLC, Smithfield RI
• Exchange: NYSE
• Planned sale date: 07/01/2025
• Recent insider sales (last 3 months): ~154 k shares

While the dollar amount is sizeable, the percentage of outstanding shares is small, suggesting limited direct dilution. Nonetheless, the continued disposition of shares by founder-linked entities may influence investor sentiment.